AGS Corporation (3648.T)
JPY 807.0
(-0.25%)
JPY 807.0
(-0.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.5 Billion | 1.71 Billion | 2.12 Billion | 1.74 Billion | 1.65 Billion | 1.98 Billion |
| Net Income | 936.46 Million | 1.03 Billion | 976.13 Million | 768.66 Million | 737.82 Million | 838.83 Million |
| Depreciation & Amortization | 1.25 Billion | 1.21 Billion | 1.27 Billion | 1.22 Billion | 1.29 Billion | 1.28 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 254.68 Million | 482.12 Million | -532.56 Million | -27.69 Million | -95.32 Million | -20.22 Million |
| Other non-cash items | 2.95 Billion | -1.01 Billion | 401.1 Million | -222.69 Million | -285.98 Million | -113.95 Million |
| Investing Cash Flow | -595.27 Million | -475.21 Million | -518.83 Million | -702.37 Million | -624.08 Million | -1.05 Billion |
| Investments in PPE | -809.92 Million | -623.38 Million | -543.19 Million | -702.53 Million | -729.1 Million | -993.8 Million |
| Acquisitions | - | - | -182.25 Million | - | -259.81 Million | - |
| Investment purchases | - | - | -12 Million | - | -10.41 Million | -240 Thousand |
| Sales/Maturities of investments | 215.51 Million | 150.65 Million | 36.38 Million | - | 100.07 Million | - |
| Other Investing Activities | -863 Thousand | -2.47 Million | 182.23 Million | 159 Thousand | 275.16 Million | -57.65 Million |
| Financing Cash Flow | -1.2 Billion | -756.48 Million | -744.15 Million | -699.28 Million | -704.12 Million | -679.91 Million |
| Debt repayment | -515.94 Million | -468.15 Million | -512.99 Million | -480.19 Million | -485.72 Million | -447.61 Million |
| Dividends payments | -210.86 Million | -195.64 Million | -231.16 Million | -195.78 Million | -196.13 Million | -196.05 Million |
| Common Stock Repurchased | -477.1 Million | -92.68 Million | - | -23.3 Million | -22.27 Million | -36.24 Million |
| Common Stock Issuance | - | 468.15 Million | - | 480.19 Million | 485.72 Million | 447.61 Million |
| Other Financing Activities | -2000.00 | -468.15 Million | -1000.00 | -480.19 Million | -485.72 Million | -447.61 Million |
| Accounts receivables | -7.94 Million | -174 Million | 344 Million | -624 Million | 131 Million | 204 Million |
| Accounts payables | -344.08 Million | 485.04 Million | -1.21 Billion | 1.39 Billion | -231.43 Million | -170.75 Million |
| Inventory | -36.56 Million | 151.17 Million | 318.35 Million | -1.02 Billion | 90.67 Million | -34.23 Million |
| Other working capital | 643.27 Million | 19.9 Million | 15.72 Million | 220.7 Million | -85.56 Million | -19.23 Million |
| Cash at beginning of period | 5.63 Billion | 5.15 Billion | 4.29 Billion | 3.94 Billion | 3.61 Billion | 3.35 Billion |
| Cash at end of period | 6.58 Billion | 5.63 Billion | 5.15 Billion | 4.29 Billion | 3.94 Billion | 3.61 Billion |
| Capital Expenditure | -809.92 Million | -623.38 Million | -543.19 Million | -702.53 Million | -729.1 Million | -993.8 Million |
| Effect of forex changes on cash | - | - | -1000.00 | - | -2000.00 | - |
| Net cash flow / Change in cash | 956.1 Million | 479.68 Million | 860.06 Million | 346.18 Million | 327 Million | 257.05 Million |
| Free Cash Flow | 1.69 Billion | 1.08 Billion | 1.57 Billion | 1.04 Billion | 926.11 Million | 994.86 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 122 Million | 89 Million | 936.46 Million | 379 Million | 288 Million | 180 Million |
| Depreciation & Amortization | - | - | 1.25 Billion | 314.24 Million | 320.37 Million | 297.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 254.68 Million | - | - | - |
| Other non-cash items | -122 Million | -89 Million | 2.95 Billion | -379 Million | -288 Million | -180 Million |
| Investing Cash Flow | - | - | -595.27 Million | - | - | - |
| Investments in PPE | - | - | -809.92 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 215.51 Million | - | - | - |
| Other Investing Activities | - | - | -863 Thousand | - | - | - |
| Financing Cash Flow | - | - | -1.2 Billion | - | - | - |
| Debt repayment | - | - | -515.94 Million | - | - | - |
| Dividends payments | - | - | -210.86 Million | - | - | - |
| Common Stock Repurchased | - | - | -477.1 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -2000.00 | - | - | - |
| Accounts receivables | - | - | -7.94 Million | - | - | - |
| Accounts payables | - | - | -344.08 Million | - | - | - |
| Inventory | - | - | -36.56 Million | - | - | - |
| Other working capital | - | - | 643.27 Million | - | - | - |
| Cash at beginning of period | - | - | 5.63 Billion | 5.78 Billion | 5.62 Billion | 5.63 Billion |
| Cash at end of period | - | - | 6.58 Billion | 6.34 Billion | 5.78 Billion | 5.62 Billion |
| Capital Expenditure | - | - | -809.92 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 956.1 Million | 562.2 Million | 162.11 Million | -8.65 Million |
| Free Cash Flow | - | - | 1.69 Billion | 628.49 Million | 640.75 Million | 595.27 Million |
BETRF
AUROPHARMA
GSTC
4058
TW
IGLD-M